Overcoming Challenges and Expanding Access to CAR T-Cell Therapy

ONCOLife presents an exclusive interview with Dr. Miguel-Angel Perales, Co-Chair of the CAR T Vision initiative and Past-President, American Society for Transplantation and Cellular Therapy. In this session, we explore the evolving landscape of CAR T-cell therapy — a groundbreaking treatment that offers the potential for long-term remission in patients with aggressive and hard-to-treat blood cancers. You can also follow this interview on LinkedIn using this link:>>>

Dr. Perales shares his expert insights on the major barriers preventing eligible patients from accessing CAR T therapy, including delayed referrals, limited treatment capacity, and systemic funding challenges. He discusses the CAR T Vision’s bold goal to double access by 2030 and outlines practical, evidence-driven strategies to make this a reality — from decentralizing care and expanding clinical capacity to engaging providers and reforming reimbursement models.

Some of the main topics in this interview include:

✅ Why so many eligible patients still can’t access CAR T-cell therapy
✅ The bold mission to double access by 2030
✅ How we can break down systemic barriers and expand treatment capacity
✅ What the future holds for CAR T and other cellular therapies